The oxidative phosphorylation system (OXPHOS) consists of five multi-enzyme complexes, Complexes I -V, and is a key component of mitochondrial function relating to energy production, oxidative stress, cell signaling and apoptosis. Defects or a reduction in activity in various components that make up the OXPHOS enzymes can cause serious diseases, including neurodegenerative disease and various metabolic disorders. Our goal is to develop techniques that are capable of rapid and in-depth analysis of all five OXPHOS complexes. Here, we describe a mild, micro-scale immunoisolation and mass spectrometric/proteomic method for the characterization of Complex II (succinate dehydrogenase) and Complex III (ubiquinol-cytochrome c reductase) from bovine and rodent heart mitochondria. Extensive protein sequence coverage was obtained after immunocapture, 1D SDS PAGE separation and mass spectrometric analysis for a majority of the 4 and 11 subunits, respectively, that make up Complexes II and III. The identification of several posttranslational modifications, including the covalent FAD modification of flavoprotein subunit 1 from Complex II, was possible due to high mass spectrometric sequence coverage. D
Introduction
The contribution of mitochondria to a variety of metabolic, neurodegenerative, and age-related diseases is still controversial, but evidence implicating mitochondrial dysfunction in these and other pathologies has increased significantly in recent years. Mitochondrial dysfunction has multiple effects, initiated as reduced energy production, that results in the formation of reactive oxygen and nitrogen species [1] , altered bioenergetic interactions within the organelle, and subsequent changes in cellular homeostasis that can lead to apoptosis or necrotic cell death [2] .
The five enzyme complexes that constitute the mitochondrial oxidative phosphorylation system (OXPHOS) contain over 90 different protein subunits, making direct and specific correlations of these to disease cause or progression difficult at best. High-resolution structures are available for all the OXPHOS complexes except Complex I (NADH:ubiquininone oxidoreductase), which contains the largest number of subunit proteins (¨46), and has a MW of 950,000 Da. Mutations in nuclear (and mitochondrial) genes of the OXPHOS complexes can cause specific human diseases and these have been reviewed recently by van den Heuvel and Smeitink [3] . Those have been associated with clinical phenotypes such as optic atrophy, tumor formation, myopathy, and encephalopathy depending on the specific subunits involved [4, 5] . OXPHOS defects are also observed in a number of late onset diseases, such as Parkinson's disease [6] , Huntington's disease [7] , and amyotrophic lateral sclerosis [8] . In these, it is thought that certain polymorphisms in the genes for the proteins of the OXPHOS system predispose to higher levels of accumulated environmental insult thereby increasing oxidative stress which, in turn, triggers cell dysfunction and ultimately cell death. However, a mitochondrial etiology of the above neurodegenerative diseases is not universally accepted.
To better investigate the role of the mitochondrial OXPHOS complexes in mitochondrial disease, better methods are needed to rapidly purify, isolate and characterize the proteins that constitute this system. As a first approach, we have used a sucrose gradient fractionation centrifugation method to isolate and partially separate the OXPHOS complexes from human heart and mouse tissue (Hanson et al. [9] and Taylor et al. [10] ). This approach led to an initial proteomic analysis of the components in each complex as well as other proteins of the mitochondrion.
More recently, our laboratories have focused on immunoisolation as a simple method for the one-step purification of the OXPHOS complexes. Isolation of Complex I from human heart [11] and from rodent tissue [12] , by this method has been combined with mass spectrometric methods for the protein identification and to evaluate sequence coverage of the individual polypeptides resolved as a necessary prerequisite for post-translational modification studies. Analogous methods have also been demonstrated for the isolation of human Complex V (ATP synthase) [13] and the pyruvate dehydrogenase complex [14] . Moreover, an immunoisolation protocol for bovine cytochrome c oxidase (Complex IV) has been developed and the enzyme studied extensively by mass spectrometry (Murray and Capaldi, unpublished data) .
In this current work, we describe a rapid and mild isolation and characterization of intact Complexes II and III from both bovine and rodent tissue followed by detailed mass spectrometric-based proteomic analysis. Both MALDI-MS peptide mass fingerprinting (PMF) and tandem mass spectrometry (nano-HPLC-MS, MS/MS) were used to identify and characterize individual protein subunits from both Complexes II and III, and this has led to the identification of several posttranslational modifications.
Materials and methods

Materials
All tissue culture materials were procured from Life Technologies/Invitrogen (Carlsbad, CA) or Cellgro (Kansas City, MO). Protease inhibitor cocktail was obtained from Roche Diagnostics (Indianapolis, IN). Antibodies coupled to protein G agarose beads for OXPHOS complex isolation were purchased from MitoSciences (Eugene, OR). NuPAGE 4 -12% Bis-Tris (MES) gels were obtained from Invitrogen (Carlsbad, CA). Materials related to proteomics, such as sample buffers, 1D SDS PAGE gels were obtained from Bio-Rad Laboratories (Hercules, CA). Gel stains, such as Coomassie Brilliant Blue R was purchased from Sigma (St. Louis, MO). For proteolysis, sequencing grade, modified trypsin (porcine) was purchased from Promega (Madison, WI). Non-ionic detergent, n-dodecyl-h-d-maltoside, and additional reagents for protein chemistry including iodoacetamide and dithiothreitol were obtained from Sigma (St. Louis, MO). HPLC solvents such as acetonitrile and water were obtained from Burdick and Jackson (Muskegon, MI). For immunoprecipitation experiments, protein G agarose beads and antibody crosslinking reagent, dimethylpimelimidate, were purchased from Sigma (St. Louis, MO). For MALDI-MS a matrix solution of a-cyano-4-hydroxycinnamic acid in acetonitrile/methanol was purchased from Agilent Technologies (Palo Alto, CA).
Preparation of bovine and mouse heart mitochondria
Bovine heart mitochondria were prepared essentially as described by Smith [15] . Briefly, ventricles in isotonic buffer (10 mM Tris -HCl pH 7.8, 0.25 M sucrose, 0.2 mM EDTA, 0.5 mM PMSF) were homogenized in an ultraturrex blender followed by a polytron tissue disruptor. Particulate material was removed filtering through cheesecloth followed by centrifugation at 1000Âg. Mitochondria were collected from the supernatant by spinning down at 12,000Âg and resuspended in the isotonic buffer. Mouse heart mitochondria were prepared by dissecting 5 mouse hearts followed by homogenization in 10 mL of the same isotonic buffer in a Potter -Elvehjem homogenizer. Particulate material was removed by centrifugation at 1000Âg. Mitochondria were then isolated by centrifugation at 12,000Âg. Protein concentration was determined by the BCA method (Pierce).
Immunocapture of Complex II and Complex III using antibody-coupled protein G agarose beads
A monoclonal antibody against Complex II (4H12B-G12AG2) was coupled to protein G agarose beads for the capture of Complex II (now available through MitoSciences, MS201). A monoclonal antibody against Complex III (1A11BC12AB9) was coupled to protein G agarose beads for the capture of Complex III (now available through MitoSciences, MS301). Immunocapture was performed as previously described [16] . Briefly, 2.5 mg of mitochondria in 0.5 mL PBS were solubilized by addition of 20 mM dodecyl-h-d-maltoside (Calbiochem) and incubation for 30 min on ice. Insoluble material was removed by centrifugation at 70,000Âg for 30 min. The recovered supernatant was incubated with 10 AL antibody-conjugated beads overnight at 4 -C while turning. Beads were washed 3 times in 1 mL PBS, 0.1 mM dodecyl-h-d-maltoside. Immunocaptured protein complexes were eluted by addition of 40 AL SDS-PAGE sample buffer (50 mM Tris pH 6.8, 2% SDS, 10% glycerol, 0.001% bromophenol blue). After the elution and discarding of the beads, the supernatant was supplemented with 50 mM DTT before electrophoresis. For electrophoresis, a 20-AL sample was resolved by SDS-PAGE on a NuPAGE 4 -12% Bis-Tris gel (Invitrogen) in an X-Cell Sure Lock Mini Cell Apparatus (Invitrogen) using MES running buffer (50 mM 2-morpholinoethanesulfonic acid, 50 mM Tris base, 0.1% SDS, 1 mM EDTA) at 100 V for 1.5 to 2 h. Alternatively, gels were run on a Tris -HCl 10 -22% acrylamide gel according to Laemmli [17] . All SDS gels were fixed with 10% methanol, 7% acetic acid for 30 min, and subsequently stained with Coomassie Brilliant Blue followed by destaining in 10% methanol/7% acetic acid.
In-gel tryptic digestion of mitochondrial proteins
Protein spots of interest were manually excised and processed with an automatic in-gel digester Robot, ProGest (Genomic Solutions, Ann Arbor, MI). The gel spots were destained and dehydrated with acetonitrile. Proteins contained within these gel spots were reduced with 10 mM DTT at 60 -C for 30 min, alkylated with 100 mM iodoacetamide (37 -C, 45 min) and proteolyzed by adding 125 -250 ng sequencing grade trypsin (Promega, Madison, WI) at 37 -C for 4 h. The resulting tryptic peptides were then extracted from the gel by aqueous/10% formic acid extraction and analyzed by mass spectrometry. In addition to tryptic digestion, gel bands were separately proteolyzed with chymotrypsin after reduction and alkylation (125 ng chymotrypsin, 25 -C, 4 h). The resulting chymotryptic peptides were extracted with 50% acetonitrile/5% formic acid, concentrated to near dryness by vacuum centrifugation (Savant) and analyzed by mass spectrometry as described below.
Mass spectrometry
Mass spectra of digested gel spots were obtained by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry on a Voyager DESTR plus (Applied Biosystems, Framingham, MA). All mass spectra were acquired in positive-ionization mode using reflectron optics. The instrument was equipped with a 337 nm nitrogen laser and operated under delayed extraction conditions; delay time 190 ns, grid voltage 66 -70% of full acceleration voltage (20 -25 kV) . All peptide samples were prepared using a matrix solution consisting of 33 mM acyano-4-hydroxycinnamic acid in acetonitrile/methanol (1/ 1; v/v); 1 AL of analyte (0.1 -1 pmol of material) was mixed with 1 AL of matrix solution, and then air-dried at room temperature on a stainless steel target. Typically, 50 -100 laser shots were used to record each spectrum. The obtained mass spectra were externally calibrated with an equimolar mixture of angiotensin I, ACTH 1-17, ACTH 18-39, and ACTH 7-38.
All proteolytic peptide extracts were analyzed by reversephase nano-HPLC-MS/MS. Briefly, peptides were separated on an Ultimate nanocapillary HPLC system equipped with a PepMapi C18 nano-column (75 Am I.D. Â 15 cm) (Dionex, Sunnyvale, CA) and CapTrap Micro guard column (0.5 AL bed volume, Michrom, Auburn, CA). Peptide mixtures were loaded onto the guard column and washed with the loading solvent (H 2 O/0.05% formic acid, 20 AL/min) for 5 min, transferred onto the analytical C 18 -nanocapillary HPLC column and then eluted at a flow rate of 300 nl/min using the following gradient: 2% B (from 0 to 5 min), and 2-70% B (from 5 -55 min). Solvent A consisted of 0.05% formic acid in 98% H 2 O/2% acetonitrile and solvent B consisted of 0.05% formic acid in 98% acetonitrile/2% H 2 O. The column eluant was directly coupled to a FQSTAR Pulsar i_ quadrupole orthogonal TOF mass spectrometer (MDS Sciex, Concorde, Canada) equipped with a Protana/ProXeon nanospray ion source (ProXeon Biosystems, Odense, Denmark). The nanospray needle voltage was typically 2300 V in the HPLC-MS mode. Mass spectra (ESI-MS) and tandem mass spectra (ESI-MS/MS) were recorded in positive-ion mode with a resolution of 12,000 -15,000 FWHM. For collision-induced dissociation tandem mass spectrometry, the mass window for precursor ion selection of the quadrupole mass analyzer was set to T1 m/z. The precursor ions were fragmented in a collision cell using nitrogen as the collision gas. All ESI-MS and MS/MS spectra were externally calibrated in static nanospray mode using MS/ MS fragment-ions of a renin peptide standard (His immonium-ion with m/z at 110.0713, and b 8 -ion with m/z at 1028.5312) providing a mass accuracy of 50 ppm.
Database searches
Mass spectrometric data were analyzed with licensed Mascot (Matrix Sciences, London, UK) bioinformatics database search engine [18] . Before submission, MALDI-MS data were first processed with Mascot Wizard v. 1.1.2 (Matrix Sciences, London, UK). The MALDI-MS Peptide Mass Fingerprint (PMF) data were matched against peptides from known protein sequences searching in-house customdesigned databases (for details, see below) using the following parameters: 100 ppm mass accuracy, 2 missed proteolytic cleavages allowed (data were internally calibrated, i.e., using trypsin autolysis masses, such as m/z 842.5100 and 2211.1046). In all cases, proteolytic digestion extracts of proteins were also analyzed by nano-HPLC-ESI-MS and MS/MS. For ESI-MS/MS data sets, spectra were submitted using Mascot Daemon to our in-house Mascot server searching in-house, custom-designed databases. Mascot uses a probability based FMowse Score_ to evaluate data obtained from tandem mass spectra, e.g., for a score >37, protein matches are considered significant [18] . For LC-MS/MS data, a minimum of two peptides were required to confirm protein identification; in the few cases where only one peptide per protein was selected for MS/MS, the MS/MS spectrum was inspected ''manually'' using similar criteria for evaluation as published by Link et al. [19] , and thus confirmed or deleted from the identification list (manual inspection is annotated in the identification Tables  1-4 ). This was particularly important for selected chymotrypsin digestion, as chymotryptic peptides do not always obtain a preferable search engine score due to their atypical fragmentation pattern.
To display the mass spectrometric data (ESI-MS/MS results), a Java program was developed, ''SeqDisp'', as previously described [12] . SeqDisp is used to graphically display the observed protein sequence coverage of peptides obtained from different proteolytic digestions performed per protein subunit, as well as to calculate overall protein sequence coverage.
Custom-designed databases and blast searches/ sequence alignment tools
Custom-designed protein databases for bovine and mouse Complexes II and III were constructed and incorporated into our in-house Mascot server to enable more in depth searches (for a complete list of accession numbers for bovine and mouse databases see Supplementary Table S1 ). Only mature OXPHOS complex protein subunits (if applicable) were entered into the databases, i.e., after processing of the precursor protein sequences that contained mitochondrial import signals as identified by homology to the mature bovine sequences. For homology studies, sequence alignment calculations were performed with the program ''SIM Alignment Tool'' [20] 
Results
In this study, intact and functional Complex II and Complex III were isolated from bovine and mouse heart mitochondria using a one-step purification method [16] . After immunoprecipitation of the intact complexes, the individual subunits were separated by 1D SDS-PAGE, visualized by Coomassie Blue staining, and select bands were subjected to mass spectrometric-based proteomic analysis.
Immunocapture of Complexes II and III from bovine and mouse tissue
The monoclonal antibodies MS201 and MS301 (MitoSciences) were used to immuno-capture and purify Complexes II and III, respectively, from bovine heart and mouse heart mitochondria. The results of these immunocapture [18] . c Molecular weight and pI were calculated for the mature protein subunits, i.e., after processing of the precursor protein sequences (if applicable) that contained mitochondrial import signals.
d MS/MS spectrum and fragmentation pattern was inspected ''manually'' and evaluated. [18] . c Molecular weight and pI were calculated for the mature protein subunits, i.e., after processing of the precursor protein sequences (if applicable) that contained mitochondrial import signals as identified by homology to the mature bovine sequences.
experiments and the subsequent separation of Complexes II and III into their protein subunits by 1D SDS PAGE are shown in Fig. 1 . Complex II was successfully immunopurified from both bovine and mouse sources before undergoing final separation by 1D SDS-PAGE (Fig. 1,  panels A and B) . All four protein subunits of bovine Complex II could be identified by mass spectrometry as visualized by Coomassie staining, while only 3 out of 4 were identified from mouse. Similarly, bovine and mouse Complex III were immunocaptured from bovine and mouse heart mitochondria, and subsequently separated by 1D SDS-PAGE (Fig. 1, panels C and D) . Overall, 10 out of 11 subunits of Complex III were identified by mass spectrometry from both bovine and mouse mitochondria, and their migration position indicated in Fig. 1C and D (for comparison, see previous report Sun et al. [21] for the analogous separation of Complex III subunits from rat heart).
To obtain a more complete sequence coverage of the immunopurified Complexes II and III from mouse and bovine heart mitochondria, a combination of MALDI-MS and nano-HPLC-ESI-MS/MS analysis was employed. The mass spectrometric results of these latter studies are listed in Tables 1-4 . Following excision from the 1D SDS-PAGE gel, protein bands were digested with trypsin and analyzed by MALDI-MS prior to analysis by HPLC ESI-MS/MS. In addition, all protein bands (except for the mouse Complex III samples) were subjected to incubation with chymotrypsin to provide overlapping sequence coverage. All the major 1D SDS gel bands visualized by Coomassie staining obtained were assigned as Complex II and Complex III subunits, demonstrating the specificity of the monoclonal antibodies and the effectiveness of the immunocapture protocol (see Fig. 1 and Tables 1-4) .
Although HPLC ESI-MS/MS provided the best overall sequence coverage, in many cases the peptide mass fingerprint data acquired by MALDI-MS was sufficient to identify the individual Complex II and III protein subunits. Presumably, these identifications were possible due the efficiency of the immunoprecipitation protocol combined by 1D SDS-PAGE separation that greatly decreased the overall sample complexity. For example, Fig. 2 shows two MALDI-MS spectra that contain molecular ions of peptides obtained after in-gel tryptic digestion of selected mouse and bovine protein bands from the 1D SDS-PAGE gels. Similarly, Fig.  2A shows 33 peptide mass fingerprints resulting from tryptic digestion of mouse Complex II protein subunit 1 that yielded a protein sequence coverage of 69% and a corresponding Mascot Mowse (M) score of 310 (a Mowse score of 25 or higher was considered significant for PMF data in this study [18] ). Likewise, Fig. 2B displays 30 peptide mass fingerprints resulting from tryptic digestion of bovine Complex III subunit 1 (69% sequence coverage; M = 253). In both cases (Panels A and B), a single unique protein subunit of Complex II or Complex III was found to be the major component present in each corresponding gel band. Several other subunits from Complexes II and III could also be assigned after tryptic digestion by MALDI-MS screening alone, with a maximum coverage of 73% (18 peptides, M = 129) for bovine Complex III-6 (see Supplement, Table S2 ).
The initial screening of the tryptic and chymotryptic samples by MALDI-MS was then followed by more detailed analyses using online nano-HPLC-ESI-MS/MS. As expected, the HPLC-MS/MS approach provided a significant increase in sequence coverage for both Complex For more details about these interacting proteins, see Supplementary Tables  S3 and S4. II and III subunits. Overall, all four protein subunits were observed for bovine Complex II, and 3 of 4 subunits for mouse Complex II. For Complex III, 10 out of the expected 11 protein subunits were identified both the bovine and mouse immunocapture experiments. The smallest protein subunit from Complex III, subunit 11 (III-11, 6.4 kDa subunit), was not identified. Tables 1-4 summarize the mass spectrometric details of protein identification, including information as to the number of peptides observed, the Mascot Mowse scores, and protein sequence coverages calculated for the mature (processed) protein subunits. Mascot database search results of the ESI-MS/MS peptide data are listed for both tryptic and chymotryptic digestions. As can be seen from these data, high protein sequence coverages were obtained for the majority of the subunits from ESI-MS/MS data of the tryptic digests alone (average coverage¨40%). This trypsin-based protein sequence coverage was improved further when combined with the chymotryptic peptide data set, yielding a combined MS/MS sequence coverage ranging from a high of 87% (II-1, mouse) to a low of 5% (III-3, bovine), with a combined average coverage of¨59% (see Tables 1 -4) .
For two of the protein subunits from Complex III (III-3 and III-9, bovine, and mouse), we observed only one tryptic peptide in each case by tandem mass spectrometry. The individual Mascot scores for bovine III-3 and III-9 were 49 and 48, respectively, which corresponds to a confident peptide assignment. Nevertheless, we manually inspected these MS/MS spectra and fragmentation pattern of these 2 peptides to confirm the identity. The CID (collision-induced dissociation) tandem mass spectrum of peptide SGPFAPVL-SATSR (residues 8 -20) from bovine Complex III subunit 9 (chain u), for example, is shown in Fig. 3 II) , III-3 (cytochrome b), III-4 (cytochrome c1), III-5 (Rieske iron-sulfur subunit), III-6 (14 kDa subunit), III-7 (9.5 kDa subunit), III-8 (11 kDa subunit), III-9 (chain u), III-10 (7.2 kDa subunit), and III-11 (6.4 kDa subunit).
b Amino acid sequence coverage of mature (processed) proteins in %, Mascot database search score according to Perkins et al. [18] . c Molecular weight and pI were calculated for the mature protein subunits, i.e., after processing of the precursor protein sequences (if applicable) that contained mitochondrial import signals.
d ESI-MS/MS spectrum and fragmentation pattern was inspected ''manually'' and evaluated (also see Fig. 3 ). 6.5 9.8 --a Complex III protein subunits (descriptive subunit names): III-1 (core protein I), III-2 (core protein II), III-3 (cytochrome b), III-4 (cytochrome c1), III-5 (Rieske iron-sulfur subunit), III-6 (14 kDa subunit), III-7 (9.5 kDa subunit), III-8 (11 kDa subunit), III-9 (chain u), III-10 (7.2 kDa subunit), and III-11 (6.4 kDa subunit).
b Amino acid sequence coverage of mature (processed) proteins in %, Mascot database search score according to Perkins et al. [18] .
c Molecular weight and pI were calculated for the mature protein subunits, i.e., after processing of the precursor protein sequences (if applicable) that contained mitochondrial import signals as identified by homology to the mature bovine sequences.
d ESI-MS/MS fragmentation pattern was inspected manually, fragmentation was compared to identical peptide observed for homologous bovine subunit.
(DVNYGWIIR, residues 72 -80) resulting from bovine Complex III subunit 3 (cytochrome b) was also inspected manually and was judged to be the correctly assigned based on an overall quality MS/MS spectrum, the presence of several b-ions and a significant y-ion series (y 1 -y 7 ), also compare similar evaluation criteria as reported by Link et al. [19] . In addition, chymotryptic digestion of these specific proteins generated additional peptides that confirmed these subunit assignments and increased the overall coverage. Interestingly, the corresponding homologous mouse proteins Complexes III-9 and III-3 obtained after immunoisolation from mouse heart, generated identical tryptic peptides, SGPFAPVLSATSR and DVNYGWIIR, as the bovine counterpart. The ESI-MS/MS spectra and fragmentation patterns of these two mouse peptides were weaker but could be compared to the fragmentation patterns obtained from the identical bovine peptides and properly validated.
As described above, all protein subunits from both bovine and mouse Complexes II and III were identified by mass spectrometry, with the exception of subunit 11 from Complex III. All of these subunits could be matched to the major bands as visualized by 1D SDS PAGE (see Fig. 1 ) after immunoprecipitation. However, some ''co-precipitating/interacting proteins'' were also identified at low to very low abundance levels in regions of the gel lane where the protein dye stain was barely visible. Most of these low abundance co-precipitating proteins were found to be subunits from other electron transport chain complexes, and may, in fact, be components of so-called Fsupercomplexes_ [22 -24] . A complete list of these co-precipitating proteins can be found in the Supplementary Tables S3 and S4.
Posttranslational modifications of Complexes II and III protein subunits
As part of our efforts to purify and identify the subunits of Complexes II and III, we also examined these separated proteins for the presence of posttranslational modifications (PTMs). The mass spectrometric dataset obtained from the immunoprecipitation experiments was therefore exhaustively searched against custom-designed databases that included all proteins for the bovine and mouse Complexes II and III (for database information see Materials and methods and Supplementary Table S1 ). Searching custom databases using our in-house Mascot server allowed us to perform less restrictive searches, essentially allowing for all possible PTMs. Using this search, we observed modifica- tions of several protein subunits including N-terminal acetylation, as well as several oxidative and non-enzymatic modifications, such as deamidation of Asn, oxidation of Trp to formylkynurenine, oxidation of Met to the sulphone, and oxidation of Cys to cysteic acid (for a more detailed list of modified subunits see Supplementary Table S5 ). An example of a modified peptide is shown in Supplementary  Fig. S1 , where the tandem mass spectrum (ESI-MS/MS) of N-acetylated peptide AGRPAVSASSR is shown, confirming previous observations [25] that the bovine Complex III protein subunit 6 (14 kDa subunit) is processed by the removal of the N-terminal methionine and N-acetylated at alanine. The analogous acetylation event was also observed for mouse Complex III subunit 6 (see Supplementary Table  S5) , which had not previously been identified.
As another example of a protein modification present in this MS data set, a tryptic peptide from mouse Complex II subunit 1 (Fp/flavoprotein subunit) corresponding to residues Ser-55 -Arg-77 (SHTVAAQGGINAALGN-MEEDNWR) was identified. This peptide, however, was shifted in mass by 783 Da corresponding to the presence of a covalently bound flavin adenine dinucleotide (FAD) group. This FAD-containing peptide was observed at m/z 1075.4 3+ (M = 3223.2 Da) and after collision-induced dissociation the spectra shown in Fig. 4 was obtained.
Although an extensive y-ion series was observed (y 1 -y 16 ), this series gave no information as to the location of the FAD group as this group appears to be located close to the Nterminus of the fragmented peptide. Caused by gas phase reactions, two abundant ions resulting from FAD itself were observed at m/z 136.1 (adenine; ''A'') and 348.1 (AMP). In contrast to the y-ion series, an extensive b*-ion series exhibited a mass shift that could be directly correlated to the position of the FAD moiety. These b*-fragment ions showed a loss of adenosine monophosphate (AMP) from the FAD modification, but with the flavin moiety attached (+436 Da) when compared to the expected masses of the unmodified bions. Overall, the fragmentation pattern clearly proved the FAD group to be covalently attached to residue His-56 as one might expect from ''prediction by similarity'' for the mouse Complex II protein subunit 1.
Discussion
In this current study, we have provided a thorough proteomic analysis of the two smallest OXPHOS components, Complexes II and III, each obtained by selective immunocapture from both mouse and bovine mitochondria. Mass spectrometric sequence analysis of the immunopurified proteins led to the identification of 4 out of the 4 subunits of bovine Complex II (3/4 for mouse Complex II), and to the identification of 10 out of the 11 subunits of bovine and mouse Complex III. The only protein subunit that was not identified in this study was Complex III subunit 11, a small 6.4 kDa protein (56 residues) that contains a 21-amino acid transmembrane domain. Although the large majority of subunits were identified with a high sequence coverage, some subunits were more difficult. For example, although bovine Complex II subunit 4, a small membraneanchoring cytochrome b associated subunit, was identified by mass spectrometry, only 3 peptides were assigned by MS/MS and these peptides were located outside the large transmembrane domain for a total sequence coverage of 16%. As the mature bovine II-4 subunit contains 103 residues (11.1 kDa) and residues 15 -35 and 70 -86 form transmembrane domains, this is not surprising. Indeed, Yang et al. [26] also described similar difficulties in identifying this subunit from E. coli that was compounded by low staining intensities with Coomassie Blue.
The monoclonal antibodies used in these studies for the immunocapture of Complexes II and III were initially described by Murray et al. [16] . Interestingly, these two antibodies were originally developed against bovine Complexes II and III, but worked equally well against the two analogous mouse complexes. This high degree of crossreactivity is not unexpected given the high sequence identity between the bovine and mouse subunits, ranging from a high of 96% to a low of 79% (see Supplementary Table S1 ). These antibodies have also proven effective in immunoprecipitating Complexes II and III from human mitochondria (data not shown) suggesting they may prove effective against other mammalian species, and possibly some nonmammalian species such as C. elegans where a high level of protein subunit sequence identity exists [27] .
The ability to obtain a high sequence coverage is a generally a necessary requirement for detecting post-translational modifications. To graphically present sequence our coverage data (see Tables 1 -4 ), a Java program named ''SeqDisp'' was developed in-house as described previously [12] . A specific case is shown in Supplementary Material (Fig. S2) where the sequence coverage of mouse Complex II subunit 2 is displayed for individual experiments using trypsin (71% coverage) and chymotrypsin (45% coverage), yielding a combined coverage of 80%. Such graphic displays of experimental sequence data were performed for each individual subunit (data not shown) and are useful to optimize experimental conditions to target specific posttranslational modifications.
With the rather extensive proteomic/mass spectrometric data set obtained in our studies, we were able to identify several posttranslational modifications, including N-terminal acetylation (see Supplementary Fig. S1 ), as well as several oxidative and non-enzymatic modifications, such as deamidation of Asn, oxidation of Trp to formylkynurenine, oxidation of Met to form a sulphone, and oxidation of Cys to form a cysteic acid (see Supplementary Table S5 ). These latter oxidative (non-enzymatic) modifications, however, need to be evaluated under more carefully controlled conditions before any biological significance can be established. Nonetheless, we were able to identify the covalent FAD modification of mouse Complex II subunit 1, the Fp (flavoprotein) subunit, and determine the site of modification as residue His-56. This histidine residue was ''predicted by similarity'' to carry the FAD modification (see Swiss-Prot entry for accession number Q8K2B3; gene name DHSA _ MOUSE), our data now validates this prediction. The FAD moiety (D = 783 Da) is quite a large covalent protein modification consisting of several components, the flavinmononucleotide (FMN) and adenosine monophosphate (AMP) [28, 29] . Previously, mass spectrometric studies have been performed on proteins and peptides containing FAD [30, 31] . It is often challenging to find conditions that maintain a covalently bound FAD group, suggesting that the immunopurification and sample handling protocols are mild enough to maintain this and other protein modifications.
Studies are now underway to identify other posttranslational modifications in these and other OXPHOS complexes, including both enzymatic (e.g., phosphorylation) and non-enzymatic modifications, especially those that might arise from oxidative stress [1, 32] . To address this latter point, we have recently developed a stable isotope methodology [33] using differential alkylation to determine the oxidative status of cysteine residues in proteins, such as glutathionylation and nitrosylation. The application of this latter method in the context of the immunopurification and proteomic characterization strategy of OXPHOS complexes described here should hopefully allow one to assess changes in the oxidation status at both the subunit and the amino acid level. In general, the ability to isolate highly purified Complexes II and III (and other OXPHOS enzymes) from rodent and other mammalian sources provides a powerful means to examine a wide variety of potential defects or modifications in specific subunits that make up these enzymes.
